Works by Kaji, Kosuke

Results: 97
    1

    Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular Carcinoma.

    Published in:
    Digestive Diseases & Sciences, 2025, v. 70, n. 6, p. 2156, doi. 10.1007/s10620-025-08884-5
    By:
    • Tsuji, Yuki;
    • Namisaki, Tadashi;
    • Takaya, Hiroaki;
    • Nishimura, Naoki;
    • Noguchi, Ryuichi;
    • Asada, Shohei;
    • Shibamoto, Akihiko;
    • Kubo, Takahiro;
    • Iwai, Satoshi;
    • Tomooka, Fumimasa;
    • Koizumi, Aritoshi;
    • Matsuda, Takuya;
    • Tanaka, Misako;
    • Yorioka, Nobuyuki;
    • Inoue, Takashi;
    • Fujinaga, Yukihisa;
    • Nishimura, Norihisa;
    • Kitagawa, Koh;
    • Sato, Shinya;
    • Kaji, Kosuke
    Publication type:
    Article
    2

    Prognostic significance of skeletal muscle mass in patients with alcohol‐related cirrhosis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 6, p. 868, doi. 10.1111/hepr.14186
    By:
    • Shibamoto, Akihiko;
    • Namisaki, Tadashi;
    • Iwai, Satoshi;
    • Tomooka, Fumimasa;
    • Kubo, Takahiro;
    • Koizumi, Aritoshi;
    • Tanaka, Misako;
    • Matsuda, Takuya;
    • Inoue, Takashi;
    • Tsuji, Yuki;
    • Fujinaga, Yukihisa;
    • Nishimura, Norihisa;
    • Sato, Shinya;
    • Kitagawa, Koh;
    • Kaji, Kosuke;
    • Mitoro, Akira;
    • Asada, Kiyoshi;
    • Takaya, Hiroaki;
    • Akahane, Takemi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    3
    4
    5
    6
    7

    Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease.

    Published in:
    JGH Open, 2020, v. 4, n. 3, p. 400, doi. 10.1002/jgh3.12264
    By:
    • Tahara, Kazuki;
    • Akahane, Takemi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kawaratani, Hideto;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Kubo, Takuya;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Tsuji, Yuuki;
    • Kaya, Daisuke;
    • Ogawa, Hiroyuki
    Publication type:
    Article
    8

    Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.

    Published in:
    Oncology Letters, 2017, v. 14, n. 3, p. 3028, doi. 10.3892/ol.2017.6489
    By:
    • Akitoshi Douhara;
    • Tadashi Namisaki;
    • Kei Moriya;
    • Mitsuteru Kitade;
    • Kosuke Kaji;
    • Hideto Kawaratani;
    • Kosuke Takeda;
    • Yasushi Okura;
    • Hiroaki Takaya;
    • Ryuichi Noguchi;
    • Norihisa Nishimura;
    • Kenichiro Seki;
    • Shinya Sato;
    • Yasuhiko Sawada;
    • Junichi Yamao;
    • Akira Mitoro;
    • Masakazu Uejima;
    • Tsuyoshi Mashitani;
    • Naotaka Shimozato;
    • Soichiro Saikawa
    Publication type:
    Article
    9
    10
    11
    12
    13

    Clinical Significance of Marginal Zinc Deficiency as a Predictor of Covert Hepatic Encephalopathy in Patients with Liver Cirrhosis.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 9, p. 4184, doi. 10.3390/ijms26094184
    By:
    • Matsuda, Takuya;
    • Namisaki, Tadashi;
    • Shibamoto, Akihiko;
    • Asada, Shohei;
    • Tomooka, Fumimasa;
    • Kubo, Takahiro;
    • Koizumi, Aritoshi;
    • Tanaka, Misako;
    • Iwai, Satoshi;
    • Inoue, Takashi;
    • Tsuji, Yuki;
    • Fujinaga, Yukihisa;
    • Nishimura, Norihisa;
    • Sato, Shinya;
    • Kitagawa, Koh;
    • Kaji, Kosuke;
    • Mitoro, Akira;
    • Asada, Kiyoshi;
    • Takaya, Hiroaki;
    • Noguchi, Ryuichi
    Publication type:
    Article
    14

    Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients.

    Published in:
    Antibiotics (2079-6382), 2020, v. 9, n. 4, p. 145, doi. 10.3390/antibiotics9040145
    By:
    • Kaji, Kosuke;
    • Saikawa, Soichiro;
    • Takaya, Hiroaki;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Kaya, Daisuke;
    • Tsuji, Yuki;
    • Sawada, Yasuhiko;
    • Kawaratani, Hideto;
    • Moriya, Kei;
    • Namisaki, Tadashi;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yoshiji, Hitoshi;
    • Leitão, Jorge H.
    Publication type:
    Article
    15
    16
    17
    18

    Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan.

    Published in:
    In Vivo, 2023, v. 37, n. 3, p. 1226, doi. 10.21873/invivo.13199
    By:
    • NOBUYUKI YORIOKA;
    • TADASHI NAMISAKI;
    • AKIHIKO SHIBAMOTO;
    • JUNYA SUZUKI;
    • TAKAHIRO KUBO;
    • SATOSHI IWAI;
    • FUMIMASA TOMOOKA;
    • MISAKO TANAKA;
    • SOICHI TAKEDA;
    • YUKI FUJIMOTO;
    • MASAHIDE ENOMOTO;
    • KOJI MUARATA;
    • TAKASHI INOUE;
    • YUKI TSUJI;
    • YUKIHISA FUJINAGA;
    • NORIHISA NISHIMURA;
    • KOH KITAGAWA;
    • HIROAKI TAKAYA;
    • KOSUKE KAJI;
    • HIDETO KAWARATANI
    Publication type:
    Article
    19

    Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy.

    Published in:
    In Vivo, 2022, v. 36, n. 3, p. 1477, doi. 10.21873/invivo.12854
    By:
    • TADASHI NAMISAKI;
    • YUKI TSUJI;
    • MITSUTERU KITADE;
    • NOBUYUKI YORIOKA;
    • YUKIHISA FUJINAGA;
    • YASUHIKO SAWADA;
    • NORIHISA NISHIMURA;
    • KOH KITAGAWA;
    • TAKASHI INOUE;
    • HIROAKI TAKAYA;
    • KOSUKE KAJI;
    • HIDETO KAWARATANI;
    • KEI MORIYA;
    • TAKEMI AKAHANE;
    • AKIRA MITORO;
    • HITOSHI YOSHIJI
    Publication type:
    Article
    20

    Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus‐related liver cirrhosis.

    Published in:
    Hepatology Research, 2024, v. 54, n. 12, p. 1116, doi. 10.1111/hepr.14077
    By:
    • Iwai, Satoshi;
    • Akahane, Takemi;
    • Takaya, Hiroaki;
    • Kubo, Takahiro;
    • Tomooka, Fumimasa;
    • Shibamoto, Akihiko;
    • Suzuki, Junya;
    • Tsuji, Yuki;
    • Fujinaga, Yukihisa;
    • Nishimura, Norihisa;
    • Kitagawa, Koh;
    • Kaji, Kosuke;
    • Kawaratani, Hideto;
    • Namisaki, Tadashi;
    • Matsumoto, Masanori;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    21
    22
    23

    Hemoglobin levels as a surrogate marker of sarcopenia in patients with liver cirrhosis.

    Published in:
    Hepatology Research, 2023, v. 53, n. 8, p. 713, doi. 10.1111/hepr.13904
    By:
    • Shibamoto, Akihiko;
    • Namisaki, Tadashi;
    • Suzuki, Junya;
    • Kubo, Takahiro;
    • Iwai, Satoshi;
    • Tomooka, Fumimasa;
    • Takeda, Soichi;
    • Fujimoto, Yuki;
    • Enomoto, Masahide;
    • Murata, Koji;
    • Inoue, Takashi;
    • Tsuji, Yuki;
    • Fujinaga, Yukihisa;
    • Nishimura, Norihisa;
    • Kitagawa, Koh;
    • Takaya, Hiroaki;
    • Kaji, Kosuke;
    • Kawaratani, Hideto;
    • Akahane, Takemi;
    • Mitoro, Akira
    Publication type:
    Article
    24

    Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute‐on‐chronic liver failure development and prognosis in patients with liver cirrhosis.

    Published in:
    Hepatology Research, 2022, v. 52, n. 4, p. 390, doi. 10.1111/hepr.13743
    By:
    • Enomoto, Masahide;
    • Takaya, Hiroaki;
    • Namisaki, Tadashi;
    • Fujinaga, Yukihisa;
    • Nishimura, Norihisa;
    • Sawada, Yasuhiko;
    • Kaji, Kosuke;
    • Kawaratani, Hideto;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Inoue, Takashi;
    • Matsumoto, Masanori;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    25
    26

    Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis.

    Published in:
    Hepatology Research, 2020, v. 50, n. 7, p. 840, doi. 10.1111/hepr.13509
    By:
    • Furukawa, Masanori;
    • Moriya, Kei;
    • Nakayama, Jiro;
    • Inoue, Takako;
    • Momoda, Rie;
    • Kawaratani, Hideto;
    • Namisaki, Tadashi;
    • Sato, Shinya;
    • Douhara, Akitoshi;
    • Kaji, Kosuke;
    • Kitade, Mitsuteru;
    • Shimozato, Naotaka;
    • Sawada, Yasuhiko;
    • Saikawa, Soichiro;
    • Takaya, Hiroaki;
    • Kitagawa, Koh;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    27

    Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1147, doi. 10.1111/hepr.13385
    By:
    • Shimozato, Naotaka;
    • Namisaki, Tadashi;
    • Kaji, Kosuke;
    • Kitade, Mitsuteru;
    • Okura, Yasushi;
    • Sato, Shinya;
    • Moriya, Kei;
    • Seki, Kenichiro;
    • Kawaratani, Hideto;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Fujinaga, Yukihisa;
    • Kubo, Takuya;
    • Asada, Kiyoshi;
    • Kitagawa, Koh;
    • Tsuji, Yuki;
    • Kaya, Daisuke
    Publication type:
    Article
    28

    Identification of clinical risk factors for histological progression of primary biliary cholangitis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 9, p. 1015, doi. 10.1111/hepr.13355
    By:
    • Fujinaga, Yukihisa;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Seki, Kenichiro;
    • Akahane, Takemi;
    • Okura, Yasushi;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Kubo, Takuya;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Tsuji, Yuki
    Publication type:
    Article
    29
    30

    Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 3, p. 284, doi. 10.1111/hepr.13281
    By:
    • Sawada, Yasuhiko;
    • Kawaratani, Hideto;
    • Kubo, Takuya;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Saikawa, Soichiro;
    • Sato, Shinya;
    • Seki, Kenichiro;
    • Takaya, Hiroaki;
    • Okura, Yasushi;
    • Kaji, Kosuke;
    • Shimozato, Naotaka;
    • Mashitani, Tsuyoshi;
    • Kitade, Mitsuteru;
    • Moriya, Kei;
    • Namisaki, Tadashi;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    31

    Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 2, p. 232, doi. 10.1111/hepr.13249
    By:
    • Okura, Yasushi;
    • Namisaki, Tadashi;
    • Sato, Shinya;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Seki, Kenichiro;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Fujinaga, Yukihisa;
    • Kubo, Takuya;
    • Kaya, Daisuke;
    • Tsuji, Yuki;
    • Ozutsumi, Takahiro
    Publication type:
    Article
    32
    33

    Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.

    Published in:
    Hepatology Research, 2017, v. 47, n. 12, p. 1317, doi. 10.1111/hepr.12860
    By:
    • Okura, Yasushi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kitade, Mitsuteru;
    • Takeda, Kosuke;
    • Kaji, Kosuke;
    • Noguchi, Ryuichi;
    • Nishimura, Norihisa;
    • Seki, Kenichiro;
    • Kawaratani, Hideto;
    • Takaya, Hiroaki;
    • Sato, Shinya;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Furukawa, Masanori;
    • Nakanishi, Keisuke;
    • Saikawa, Soichiro;
    • Kubo, Takuya;
    • Asada, Kiyoshi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    34

    Predictive parameter of tolvaptan effectiveness in cirrhotic ascites.

    Published in:
    Hepatology Research, 2017, v. 47, n. 9, p. 854, doi. 10.1111/hepr.12826
    By:
    • Kawaratani, Hideto;
    • Fukui, Hiroshi;
    • Moriya, Kei;
    • Noguchi, Ryuichi;
    • Namisaki, Tadashi;
    • Uejima, Masakazu;
    • Kitade, Mitsuteru;
    • Takeda, Kosuke;
    • Okura, Yasushi;
    • Kaji, Kosuke;
    • Nishimura, Norihisa;
    • Takaya, Hiroaki;
    • Aihara, Yousuke;
    • Sawada, Yasuhiko;
    • Sato, Shinya;
    • Seki, Kenichiro;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    35

    Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis.

    Published in:
    Hepatology Research, 2017, v. 47, n. 3, p. E178, doi. 10.1111/hepr.12746
    By:
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Noguchi, Ryuichi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Yamao, Junichi;
    • Mitoro, Akira;
    • Yoshida, Motoyuki;
    • Sawai, Masayoshi;
    • Uejima, Masakazu;
    • Mashitani, Tsuyoshi;
    • Takeda, Kosuke;
    • Okura, Yasushi;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Aihara, Yosuke;
    • Douhara, Akitoshi;
    • Nishimura, Norihisa;
    • Sawada, Yasuhiko;
    • Sato, Shinya
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B.

    Published in:
    Experimental & Therapeutic Medicine, 2020, v. 20, n. 2, p. 985, doi. 10.3892/etm.2020.8798
    By:
    • Tsuji, Yuki;
    • Namisaki, Tadashi;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Nakanishi, Keisuke;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Sawada, Yasuhiko;
    • Kitagawa, Kou;
    • Shimozato, Naotaka;
    • Kawaratani, Hideto;
    • Moriya, Kei;
    • Noguchi, Ryuichi;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    42

    Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infection.

    Published in:
    Experimental & Therapeutic Medicine, 2018, v. 16, n. 3, p. 2743, doi. 10.3892/etm.2018.6481
    By:
    • Takeda, Kosuke;
    • Noguchi, Ryuichi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Seki, Kenichiro;
    • Fujinaga, Yukihisa;
    • Tsuji, Yuki;
    • Kubo, Takuya;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Kitagawa, Koh
    Publication type:
    Article
    43
    44

    Calcified mucinous adenocarcinoma of the stomach metastatic to the iris: a case report.

    Published in:
    2019
    By:
    • Kaneko, Miki;
    • Namisaki, Tadashi;
    • Takaya, Hiroaki;
    • Mori, Hitoshi;
    • Kitade, Mitsuteru;
    • Okura, Yasushi;
    • Seki, Kenichiro;
    • Sato, Shinya;
    • Nakanishi, Keisuke;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Otani, Tomoyuki;
    • Nakai, Tokiko;
    • Obayashi, Chiho;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Yoshiji, Hitoshi
    Publication type:
    journal article
    45
    46
    47
    48

    VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.

    Published in:
    Digestive Diseases & Sciences, 2024, v. 69, n. 3, p. 851, doi. 10.1007/s10620-023-08257-w
    By:
    • Asada, Shohei;
    • Namisaki, Tadashi;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Kubo, Takahiro;
    • Akahane, Takemi;
    • Kawaratani, Hideto;
    • Nishimura, Norihisa;
    • Takeda, Soichi;
    • Masuda, Hiroyuki;
    • Shibamoto, Akihiko;
    • Inoue, Takashi;
    • Iwai, Satoshi;
    • Tomooka, Fumimasa;
    • Tsuji, Yuki;
    • Fujinaga, Yukihisa;
    • Kitagawa, Koh;
    • Mitoro, Akira;
    • Sato, Shinya;
    • Matsumoto, Masanori
    Publication type:
    Article
    49

    Plasma copeptin concentration is a predictor of tolvaptan efficacy in patients with hepatic ascites.

    Published in:
    Portal Hypertension & Cirrhosis, 2023, v. 2, n. 3, p. 109, doi. 10.1002/poh2.55
    By:
    • Tomooka, Fumimasa;
    • Moriya, Kei;
    • Kubo, Takahiro;
    • Shibamoto, Akihiko;
    • Suzuki, Jyunya;
    • Iwai, Satoshi;
    • Takeda, Soichi;
    • Fujimoto, Yuki;
    • Enomoto, Masahide;
    • Murata, Koji;
    • Tsuji, Yuki;
    • Fujinaga, Yukihisa;
    • Kitagawa, Koh;
    • Nishimura, Norihisa;
    • Takaya, Hiroaki;
    • Kaji, Kosuke;
    • Kawaratani, Hideto;
    • Namisaki, Tadashi;
    • Akahane, Takemi;
    • Mitoro, Akira
    Publication type:
    Article
    50